Resmed Inc. buy KeyCorp
Start price
31.01.25
/
50%
€232.00
Target price
31.01.26
€269.28
Performance (%)
-7.63%
End price
01.02.26
€214.30
Summary
This prediction ended on 01.02.26 with a price of €214.30. With a performance of -7.63%, the BUY prediction for Resmed Inc. by KeyCorp closed slightly in the red. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €0.51 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.702% | 2.702% | -23.752% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $266.00 to $280.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten